LON:PRTC PureTech Health (PRTC) Share Price, News & Analysis GBX 141.40 -5.40 (-3.68%) (As of 10/1/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesInsider Trades About PureTech Health Stock (LON:PRTC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PureTech Health alerts:Sign Up Key Stats Today's Range 140.60▼ 149.6050-Day Range 141.80▼ 17852-Week Range 139▼ 238.50Volume760,918 shsAverage Volume565,003 shsMarket Capitalization£338.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. In addition, the company is developing drug delivery platform for oral administration of proteins, peptides, and other difficult-to-deliver payloads; products to generate new human hair follicles and hair; drug delivery platform for drugs that treat inflammation and associated disorders; platform to address immunosenescence; novel targeted immunotherapies for cancer; monoclonal antibodies for immuno-suppressive gamma delta T cells in pancreatic and colorectal cancers, and other solid tumors; novel approaches to enhance delivery and distribution of therapeutics; and digital health technologies, as well as engages in enhancing health through food through the creation of nutrition technology. Further, it is developing a platform and products that take in physiological data from sensors and correlates that data with musical data components; voice-based tools for passive assessment and tracking of patient health; commensal organism-based products for enhancing human health; and technology platform to identify experts in healthcare and other research-based disciplines, as well as engages in identifying healthcare expert networks and reviewing their conversations and content on social media. The company was incorporated in 2015 and is based in Boston, Massachusetts.Read More… $20 = Ounce of Gold? (Ad)I've discovered a way to get exposure to MORE than an ounce of gold... for under $20. It's not bullion. It's not ETFs. And it's certainly not crypto.Click here to find out why this is my favorite gold stock. Receive PRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address PRTC Stock News HeadlinesFDA approves PureTech’s KarXT to treat schizophrenia in adultsSeptember 30 at 11:22 AM | finance.yahoo.comAfter hitting a five-year low I’m betting this hidden gem will rocket like the Rolls-Royce share priceSeptember 25, 2024 | fool.co.ukNext Week Elon Could Trigger a Boom in this Sub-$3 Stock Next week, you’ll have a chance to get in on the ground floor of what could be Elon’s next big thing. You see, he’s set to reveal his new AI product that I believe will shock the world… October 2, 2024 | InvestorPlace (Ad)Analyst starts PureTech Health coverage with Outperform, notes potential in deuterated moleculesSeptember 11, 2024 | investing.comPureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted TherapiesSeptember 6, 2024 | finance.yahoo.comOptimistic Outlook for PureTech Health: Strong Pipeline and Financial Strategy Justify Buy RatingAugust 30, 2024 | markets.businessinsider.comPureTech Health plc (NASDAQ:PRTC) Q2 2024 Earnings Call TranscriptAugust 29, 2024 | msn.comPureTech Health plc (PRTC) Q2 2024 Earnings Call TranscriptAugust 28, 2024 | seekingalpha.comSee More Headlines PRTC Stock Analysis - Frequently Asked Questions How have PRTC shares performed this year? PureTech Health's stock was trading at GBX 194.20 at the beginning of 2024. Since then, PRTC shares have decreased by 27.2% and is now trading at GBX 141.40. View the best growth stocks for 2024 here. How do I buy shares of PureTech Health? Shares of PRTC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of PureTech Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that PureTech Health investors own include Nemaska Lithium (NMX), Yamana Gold (YRI), Asanko Gold (AKG), Arotech (ARTX), Boeing (BA), Baozun (BZUN) and Chaarat Gold (CGH). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:PRTC CUSIPN/A CIKN/A Webpuretechhealth.com Phone+1-617-4822333FaxN/AEmployees300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-82,470,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-22.07% Return on Assets-13.39% Debt Debt-to-Equity Ratio47.27 Current Ratio3.68 Quick Ratio2.51 Sales & Book Value Annual Sales£3.33 million Price / Sales101.66 Cash FlowGBX 66.02 per share Price / Cash Flow2.14 Book ValueGBX 132 per share Price / Book1.07Miscellaneous Outstanding Shares239,420,000Free FloatN/AMarket Cap£338.54 million OptionableNot Optionable Beta1.02 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (LON:PRTC) was last updated on 10/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredThey laughed when he picked Nvidia in 2016…Everyone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredFor Elon, I fear the worst is yet to come…Early last year I predicted that there would be a war on Elon Musk. This hateful rhetoric has led to two s...Porter & Company | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.